Rajanandini Muralidharan

Rajanandini Muralidharan practices at NYU Langone Hospitals - Long Island in Mineola, New York.

Rajanandini Muralidharan's NPI, 1174785802, was assigned on June 25, 2008. Rajanandini Muralidharan graduated from State University of New York Downstate Medical Center in 2007. Rajanandini Muralidharan holds Minnesota license 51211.

Rajanandini Muralidharan's primary practice is NYU Langone Hospitals - Long Island, at 259 1st St, Mineola, NY 11501 in Nassau County. The practice phone is (516) 576-1820.

Rajanandini Muralidharan's primary practice is NYU Langone Hospitals - Long Island in Mineola, New York. Rajanandini Muralidharan is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Rajanandini Muralidharan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rajanandini Muralidharan practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Rajanandini Muralidharan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Rajanandini Muralidharan is board certified in neurocritical care by the American Board of Emergency Medicine. Rajanandini Muralidharan is licensed in Minnesota.

CMS data shows 238 Medicare services from Rajanandini Muralidharan across 2 procedure codes in 2024, for 97 Medicare patients. Medicare paid $33,036 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Rajanandini Muralidharan in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rajanandini Muralidharan's median patient age at 68, with 40% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Rajanandini Muralidharan for performance year 2024, reported as part of a group. Rajanandini Muralidharan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Rajanandini Muralidharan, published from 2011 to 2025. 2013 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, Brain and Brain Death. Rajanandini Muralidharan has published most often in Arch Neurol. Rajanandini Muralidharan's most frequent co-authors are Farrah J. Mateen, MD, John L. D. Atkinson, MD and Giuseppe Lanzino, MD.

CMS Open Payments shows 18 general payments to Rajanandini Muralidharan from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. AstraZeneca Pharmaceuticals LP paid the most, $614.

Rajanandini Muralidharan graduated from State University of New York Downstate Medical Center in 2007.